应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
ZNTL Zentalis Pharmaceuticals, LLC
交易中 12-20 13:37:50 EST
3.06
+0.13
+4.44%
最高
3.10
最低
2.89
成交量
49.74万
今开
2.90
昨收
2.93
日振幅
7.17%
总市值
2.18亿
流通市值
1.58亿
总股本
7,127万
成交额
149.83万
换手率
0.96%
流通股本
5,162万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Zentalis Pharmaceuticals, Inc.盘中异动 股价大跌5.11%报2.97美元
市场透视 · 12-19 00:12
Zentalis Pharmaceuticals, Inc.盘中异动 股价大跌5.11%报2.97美元
Zentalis Pharmaceuticals, Inc.盘中异动 急速下跌5.01%报3.70美元
市场透视 · 12-10
Zentalis Pharmaceuticals, Inc.盘中异动 急速下跌5.01%报3.70美元
Zentalis Pharmaceuticals, Inc.盘中异动 快速上涨6.57%
市场透视 · 12-09
Zentalis Pharmaceuticals, Inc.盘中异动 快速上涨6.57%
Zentalis Pharmaceuticals, Inc.盘中异动 大幅上涨5.09%报3.51美元
市场透视 · 12-06
Zentalis Pharmaceuticals, Inc.盘中异动 大幅上涨5.09%报3.51美元
Zentalis Pharmaceuticals, Inc.盘中异动 早盘快速跳水6.56%报3.42美元
市场透视 · 12-03
Zentalis Pharmaceuticals, Inc.盘中异动 早盘快速跳水6.56%报3.42美元
Zentalis Pharmaceuticals, Inc.盘中异动 快速拉升5.12%报3.80美元
市场透视 · 12-03
Zentalis Pharmaceuticals, Inc.盘中异动 快速拉升5.12%报3.80美元
Zentalis Pharmaceuticals, Inc.盘中异动 急速上涨5.03%报3.66美元
市场透视 · 11-27
Zentalis Pharmaceuticals, Inc.盘中异动 急速上涨5.03%报3.66美元
Zentalis Pharmaceuticals, Inc.盘中异动 早盘股价大涨7.12%
市场透视 · 11-25
Zentalis Pharmaceuticals, Inc.盘中异动 早盘股价大涨7.12%
Zentalis Pharmaceuticals, Inc.盘中异动 大幅拉升5.03%
市场透视 · 11-23
Zentalis Pharmaceuticals, Inc.盘中异动 大幅拉升5.03%
Zentalis Pharmaceuticals, Inc.盘中异动 快速拉升5.34%
市场透视 · 11-20
Zentalis Pharmaceuticals, Inc.盘中异动 快速拉升5.34%
Zentalis Pharmaceuticals, Inc.盘中异动 股价大跌5.91%报3.27美元
市场透视 · 11-18
Zentalis Pharmaceuticals, Inc.盘中异动 股价大跌5.91%报3.27美元
Zentalis Pharmaceuticals, Inc.盘中异动 股价大涨5.10%
市场透视 · 11-14
Zentalis Pharmaceuticals, Inc.盘中异动 股价大涨5.10%
Zentalis 制药公司公布本季度业绩 - 收益摘要
路透中文 · 11-14
Zentalis 制药公司公布本季度业绩 - 收益摘要
Zentalis Pharmaceuticals, Inc.盘中异动 早盘股价大涨11.59%报4.14美元
市场透视 · 11-13
Zentalis Pharmaceuticals, Inc.盘中异动 早盘股价大涨11.59%报4.14美元
Zentalis Pharmaceuticals, Inc.盘中异动 大幅上涨5.25%报4.01美元
市场透视 · 11-08
Zentalis Pharmaceuticals, Inc.盘中异动 大幅上涨5.25%报4.01美元
Zentalis Pharmaceuticals, Inc.盘中异动 股价大涨5.08%报4.04美元
市场透视 · 11-07
Zentalis Pharmaceuticals, Inc.盘中异动 股价大涨5.08%报4.04美元
Zentalis Pharmaceuticals, Inc.盘中异动 早盘大幅拉升5.29%报3.98美元
市场透视 · 11-06
Zentalis Pharmaceuticals, Inc.盘中异动 早盘大幅拉升5.29%报3.98美元
Zentalis Pharmaceuticals Inc 预计每股亏损 91 美分 - 财报前瞻
Reuters · 11-06
Zentalis Pharmaceuticals Inc 预计每股亏损 91 美分 - 财报前瞻
Zentalis Pharmaceuticals, Inc.盘中异动 股价大跌5.09%
市场透视 · 11-05
Zentalis Pharmaceuticals, Inc.盘中异动 股价大跌5.09%
Zentalis Pharmaceuticals, Inc.盘中异动 股价大涨5.12%报3.49美元
市场透视 · 11-04
Zentalis Pharmaceuticals, Inc.盘中异动 股价大涨5.12%报3.49美元
加载更多
公司概况
公司名称:
Zentalis Pharmaceuticals, LLC
所属市场:
NASDAQ
上市日期:
--
主营业务:
Zentalis Pharmaceuticals, Inc.于2014年12月23日在特拉华州以Zeno Pharmaceuticals,Inc.的身份注册成立。Zentalis Pharmaceuticals,Inc.是一家临床阶段制药公司,致力于发现和开发针对癌症基本生物途径的临床分化的新型小分子疗法。
发行价格:
--
{"stockData":{"symbol":"ZNTL","market":"US","secType":"STK","nameCN":"Zentalis Pharmaceuticals, LLC","latestPrice":3.06,"timestamp":1734719867521,"preClose":2.93,"halted":0,"volume":497381,"delay":0,"floatShares":51621099,"shares":71265400,"eps":-2.526158,"marketStatus":"交易中","marketStatusCode":2,"change":0.13,"latestTime":"12-20 13:37:50 EST","open":2.9,"high":3.1,"low":2.89,"amount":1498262.2287049,"amplitude":0.071672,"askPrice":3.07,"askSize":1330,"bidPrice":3.06,"bidSize":1234,"shortable":3,"etf":0,"ttmEps":-2.526158,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1734728400000},"adr":0,"listingDate":1585886400000,"adjPreClose":2.93,"preHourTrading":{"tag":"盘前","latestPrice":2.95,"preClose":2.93,"latestTime":"09:03 EST","volume":213,"amount":644.299653,"timestamp":1734703436470},"postHourTrading":{"tag":"盘后","latestPrice":2.91,"preClose":2.93,"latestTime":"17:23 EST","volume":10565,"amount":30935.5,"timestamp":1734647014381},"volumeRatio":0.554569,"impliedVol":2.8422,"impliedVolPercentile":0.9325},"requestUrl":"/m/hq/s/ZNTL","defaultTab":"news","newsList":[{"id":"2492133924","title":"Zentalis Pharmaceuticals, Inc.盘中异动 股价大跌5.11%报2.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492133924","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492133924?lang=zh_cn&edition=full","pubTime":"2024-12-19 00:12","pubTimestamp":1734538367,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日00时12分,Zentalis Pharmaceuticals, Inc.股票出现波动,股价大幅跳水5.11%。Zentalis Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.33%。其相关个股中,Polyrizon Ltd.、Cognition Therapeutics, Inc.、Surrozen Inc C/Wts 01/08/2031 涨幅较大,Polyrizon Ltd.、Cognition Therapeutics, Inc.、Tc Biopharm Plc较为活跃,换手率分别为2651.02%、520.81%、304.82%,振幅较大的相关个股有Polyrizon Ltd.、Cognition Therapeutics, Inc.、Nkgen Biotech Inc C/Wts 31/05/2028,振幅分别为227.62%、118.27%、66.83%。Zentalis Pharmaceuticals, Inc.公司简介:Zentalis Pharmaceuticals Inc是一家临床阶段的生物制药公司,专注于发现和开发针对癌症基本生物学途径的小分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219001247a1f8eea8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219001247a1f8eea8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZNTL","BK4007","CGTX","BK4139"],"gpt_icon":0},{"id":"2490433210","title":"Zentalis Pharmaceuticals, Inc.盘中异动 急速下跌5.01%报3.70美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490433210","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490433210?lang=zh_cn&edition=full","pubTime":"2024-12-10 23:07","pubTimestamp":1733843255,"startTime":"0","endTime":"0","summary":"北京时间2024年12月10日23时07分,Zentalis Pharmaceuticals, Inc.股票出现异动,股价快速跳水5.01%。Zentalis Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为1.22%。其相关个股中,Chimerix, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Uniqure N.V.涨幅较大,Psyence Biomedical Ltd.、Processa Pharmaceuticals, Inc.、60 Degrees Pharmaceuticals, Inc.较为活跃,换手率分别为1888.91%、431.08%、104.13%,振幅较大的相关个股有Chimerix, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Psyence Biomedical Ltd.,振幅分别为138.72%、131.78%、38.65%。Zentalis Pharmaceuticals, Inc.公司简介:Zentalis Pharmaceuticals Inc是一家临床阶段的生物制药公司,专注于发现和开发针对癌症基本生物学途径的小分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241210230735ab6d06af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241210230735ab6d06af&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ZNTL"],"gpt_icon":0},{"id":"2490577936","title":"Zentalis Pharmaceuticals, Inc.盘中异动 快速上涨6.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490577936","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490577936?lang=zh_cn&edition=full","pubTime":"2024-12-09 22:33","pubTimestamp":1733754797,"startTime":"0","endTime":"0","summary":"北京时间2024年12月09日22时33分,Zentalis Pharmaceuticals, Inc.股票出现异动,股价急速上涨6.57%。Zentalis Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.19%。其相关个股中,60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Sonnet Biotherapeutics Holdings, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大,Sonnet Biotherapeutics Holdings, Inc.、Dermata Therapeutics, Inc.、Entero Therapeutics Inc.较为活跃,换手率分别为2432.77%、23.78%、19.98%,振幅较大的相关个股有Tnf Pharmaceuticals, Inc.、Alector, Inc.、Bioxcel Therapeutics, Inc.,振幅分别为117.73%、111.36%、110.35%。Zentalis Pharmaceuticals, Inc.公司简介:Zentalis Pharmaceuticals Inc是一家临床阶段的生物制药公司,专注于发现和开发针对癌症基本生物学途径的小分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120922331795e8684c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120922331795e8684c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ZNTL"],"gpt_icon":0},{"id":"2489234359","title":"Zentalis Pharmaceuticals, Inc.盘中异动 大幅上涨5.09%报3.51美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489234359","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489234359?lang=zh_cn&edition=full","pubTime":"2024-12-06 23:03","pubTimestamp":1733497414,"startTime":"0","endTime":"0","summary":"北京时间2024年12月06日23时03分,Zentalis Pharmaceuticals, Inc.股票出现波动,股价大幅拉升5.09%。Zentalis Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.54%。其相关个股中,Immatics N V C/Wts 01/07/2025 、Dermata Therapeutics Inc C/Wts 、Cardio Diagnostics Holdings Inc.涨幅较大,Molecular Templates, Inc.、Psyence Biomedical Ltd.、Cardio Diagnostics Holdings Inc.较为活跃,换手率分别为42.62%、33.46%、21.62%,振幅较大的相关个股有Cero Therapeutics Holdings, Inc.、Cardio Diagnostics Holdings Inc.、Aprea Therapeutics, Inc.,振幅分别为27.68%、24.33%、18.99%。Zentalis Pharmaceuticals, Inc.公司简介:Zentalis Pharmaceuticals Inc是一家临床阶段的生物制药公司,专注于发现和开发针对癌症基本生物学途径的小分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120623033498e5e333&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120623033498e5e333&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ZNTL"],"gpt_icon":0},{"id":"2488497946","title":"Zentalis Pharmaceuticals, Inc.盘中异动 早盘快速跳水6.56%报3.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488497946","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488497946?lang=zh_cn&edition=full","pubTime":"2024-12-03 22:38","pubTimestamp":1733236727,"startTime":"0","endTime":"0","summary":"北京时间2024年12月03日22时38分,Zentalis Pharmaceuticals, Inc.股票出现波动,股价大幅下跌6.56%。Zentalis Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.17%。其相关个股中,Janux Therapeutics, Inc.、Coherus Biosciences, Inc.、Cytomx Therapeutics, Inc.涨幅较大,Nls Pharmaceutics Ltd.、Purple Biotech Ltd、Quoin Pharmaceuticals Ltd较为活跃,换手率分别为131.95%、72.76%、57.85%,振幅较大的相关个股有Coherus Biosciences, Inc.、Senti Biosciences, Inc.、万春医药,振幅分别为24.09%、21.00%、14.79%。Zentalis Pharmaceuticals, Inc.公司简介:Zentalis Pharmaceuticals Inc是一家临床阶段的生物制药公司,专注于发现和开发针对癌症基本生物学途径的小分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120322384798e51c1c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120322384798e51c1c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ZNTL"],"gpt_icon":0},{"id":"2488560503","title":"Zentalis Pharmaceuticals, Inc.盘中异动 快速拉升5.12%报3.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488560503","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488560503?lang=zh_cn&edition=full","pubTime":"2024-12-03 00:43","pubTimestamp":1733157794,"startTime":"0","endTime":"0","summary":"北京时间2024年12月03日00时43分,Zentalis Pharmaceuticals, Inc.股票出现异动,股价快速拉升5.12%。Zentalis Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.20%。其相关个股中,Senti Biosciences, Inc.、Purple Biotech Ltd、Cingulate Inc C/Wts 10/12/2026 涨幅较大,Senti Biosciences, Inc.、Purple Biotech Ltd、Quoin Pharmaceuticals Ltd较为活跃,换手率分别为2087.65%、1974.82%、446.99%,振幅较大的相关个股有Senti Biosciences, Inc.、Purple Biotech Ltd、Quoin Pharmaceuticals Ltd,振幅分别为481.02%、289.12%、131.67%。Zentalis Pharmaceuticals, Inc.公司简介:Zentalis Pharmaceuticals Inc是一家临床阶段的生物制药公司,专注于发现和开发针对癌症基本生物学途径的小分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203004314abf041be&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203004314abf041be&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ZNTL"],"gpt_icon":0},{"id":"2486074878","title":"Zentalis Pharmaceuticals, Inc.盘中异动 急速上涨5.03%报3.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486074878","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486074878?lang=zh_cn&edition=full","pubTime":"2024-11-27 23:02","pubTimestamp":1732719760,"startTime":"0","endTime":"0","summary":"北京时间2024年11月27日23时02分,Zentalis Pharmaceuticals, Inc.股票出现异动,股价急速拉升5.03%。Zentalis Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.31%。其相关个股中,Celularity Inc C/Wts 16/07/2026 、Tuhura Biosciences, Inc.、Cyclerion Therapeutics, Inc.涨幅较大,Cyclerion Therapeutics, Inc.、Outlook Therapeutics, Inc.、Elevai Labs, Inc.较为活跃,换手率分别为907.03%、55.71%、12.10%,振幅较大的相关个股有Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Briacell Therapeutics Corp C/Wts 24/02/2025、Cyclerion Therapeutics, Inc.,振幅分别为45.15%、35.46%、34.56%。Zentalis Pharmaceuticals, Inc.公司简介:Zentalis Pharmaceuticals Inc是一家临床阶段的生物制药公司,专注于发现和开发针对癌症基本生物学途径的小分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127230240abe3794d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127230240abe3794d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZNTL","BK4139"],"gpt_icon":0},{"id":"2486403820","title":"Zentalis Pharmaceuticals, Inc.盘中异动 早盘股价大涨7.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486403820","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486403820?lang=zh_cn&edition=full","pubTime":"2024-11-25 22:33","pubTimestamp":1732545228,"startTime":"0","endTime":"0","summary":"北京时间2024年11月25日22时33分,Zentalis Pharmaceuticals, Inc.股票出现波动,股价急速拉升7.12%。Zentalis Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为1.06%。其相关个股中,Scholar Rock Holding Corporation、Bridgebio Pharma, Inc.、Citius Pharmaceuticals, Inc.涨幅较大,Cognition Therapeutics, Inc.、木薯科学、Citius Pharmaceuticals, Inc.较为活跃,换手率分别为87.24%、61.67%、38.71%,振幅较大的相关个股有Anixa Biosciences, Inc.、Werewolf Therapeutics, Inc.、Kodiak Sciences Inc,振幅分别为105.47%、105.26%、105.01%。Zentalis Pharmaceuticals, Inc.公司简介:Zentalis Pharmaceuticals Inc是一家临床阶段的生物制药公司,专注于发现和开发针对癌症基本生物学途径的小分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125223349a2548d8c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125223349a2548d8c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZNTL","BK4139"],"gpt_icon":0},{"id":"2485293547","title":"Zentalis Pharmaceuticals, Inc.盘中异动 大幅拉升5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485293547","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485293547?lang=zh_cn&edition=full","pubTime":"2024-11-23 00:12","pubTimestamp":1732291952,"startTime":"0","endTime":"0","summary":"北京时间2024年11月23日00时12分,Zentalis Pharmaceuticals, Inc.股票出现异动,股价快速拉升5.03%。Zentalis Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.52%。其相关个股中,Apollomics Inc C/Wts 01/04/2028 、Replimune Group, Inc.、Exicure, Inc.涨幅较大,Virpax Pharmaceuticals, Inc.、Exicure, Inc.、Molecular Templates, Inc.较为活跃,换手率分别为1750.64%、122.29%、88.63%,振幅较大的相关个股有Apollomics Inc C/Wts 01/04/2028 、Virpax Pharmaceuticals, Inc.、Exicure, Inc.,振幅分别为63.64%、62.35%、45.86%。Zentalis Pharmaceuticals, Inc.公司简介:Zentalis Pharmaceuticals Inc是一家临床阶段的生物制药公司,专注于发现和开发针对癌症基本生物学途径的小分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123001232abd7bcb7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123001232abd7bcb7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZNTL","BK4139"],"gpt_icon":0},{"id":"2484143872","title":"Zentalis Pharmaceuticals, Inc.盘中异动 快速拉升5.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484143872","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484143872?lang=zh_cn&edition=full","pubTime":"2024-11-20 22:58","pubTimestamp":1732114709,"startTime":"0","endTime":"0","summary":"北京时间2024年11月20日22时58分,Zentalis Pharmaceuticals, Inc.股票出现波动,股价大幅拉升5.34%。Zentalis Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.45%。其相关个股中,Klotho Neurosciences Inc C/Wts 21/06/2029 、Forte Biosciences, Inc.、Silexion Therapeutics Corp涨幅较大,Silexion Therapeutics Corp、Forte Biosciences, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃,换手率分别为930.19%、416.57%、166.36%,振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Silexion Therapeutics Corp,振幅分别为163.37%、65.87%、56.10%。Zentalis Pharmaceuticals, Inc.公司简介:Zentalis Pharmaceuticals Inc是一家临床阶段的生物制药公司,专注于发现和开发针对癌症基本生物学途径的小分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120225829a248cf44&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120225829a248cf44&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ZNTL"],"gpt_icon":0},{"id":"2484167426","title":"Zentalis Pharmaceuticals, Inc.盘中异动 股价大跌5.91%报3.27美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484167426","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484167426?lang=zh_cn&edition=full","pubTime":"2024-11-18 22:53","pubTimestamp":1731941580,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日22时53分,Zentalis Pharmaceuticals, Inc.股票出现异动,股价急速下挫5.91%。Zentalis Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.35%。其相关个股中,Hcw Biologics Inc.、冠科美博、Apollomics Inc C/Wts 01/04/2028 涨幅较大,Tharimmune, Inc.、Hcw Biologics Inc.、冠科美博较为活跃,换手率分别为547.20%、409.52%、298.08%,振幅较大的相关个股有Hcw Biologics Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Fate Therapeutics, Inc.,振幅分别为118.81%、71.83%、62.38%。Zentalis Pharmaceuticals, Inc.公司简介:Zentalis Pharmaceuticals Inc是一家临床阶段的生物制药公司,专注于发现和开发针对癌症基本生物学途径的小分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822530198e43452&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822530198e43452&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZNTL","BK4139"],"gpt_icon":0},{"id":"2483047608","title":"Zentalis Pharmaceuticals, Inc.盘中异动 股价大涨5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483047608","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483047608?lang=zh_cn&edition=full","pubTime":"2024-11-14 22:33","pubTimestamp":1731594813,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日22时33分,Zentalis Pharmaceuticals, Inc.股票出现波动,股价快速拉升5.10%。Zentalis Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.45%。Zentalis Pharmaceuticals, Inc.公司简介:Zentalis Pharmaceuticals Inc是一家临床阶段的生物制药公司,专注于发现和开发针对癌症基本生物学途径的小分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111422333398e42a20&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111422333398e42a20&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4183","BK4139","ZNTL","ELAB"],"gpt_icon":0},{"id":"2483587852","title":"Zentalis 制药公司公布本季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2483587852","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483587852?lang=zh_cn&edition=full","pubTime":"2024-11-14 04:23","pubTimestamp":1731529429,"startTime":"0","endTime":"0","summary":"Zentalis 制药公司公布本季度业绩 - 收益摘要Zentalis Pharmaceuticals Inc ZNTL.OQ报告本季度调整后每股亏损56美分,高于去年同期的每股-79美分。华尔街预期为每股亏损-99 美分至-81 美分。Zentalis Pharmaceuticals Inc 报告的季度每股收益为亏损 56 美分。该公司当季亏损 4016 万美元。Zentalis Pharmaceuticals Inc 本季度股价上涨了 0.8%,今年迄今为止亏损了 75.5%。华尔街对 Zentalis Pharmaceuticals Inc 的 12 个月目标价中位数为 8.00 美元。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241113:nL4T3MK21T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZNTL","BK4139"],"gpt_icon":0},{"id":"2483845728","title":"Zentalis Pharmaceuticals, Inc.盘中异动 早盘股价大涨11.59%报4.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483845728","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483845728?lang=zh_cn&edition=full","pubTime":"2024-11-13 22:32","pubTimestamp":1731508353,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日22时32分,Zentalis Pharmaceuticals, Inc.股票出现波动,股价快速拉升11.59%。Zentalis Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.15%。其相关个股中,Celularity Inc C/Wts 16/07/2026 、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Mersana Therapeutics, Inc.涨幅较大,Cyclacel Pharmaceuticals, Inc.、Elevai Labs, Inc.、Tharimmune, Inc.较为活跃,换手率分别为329.98%、176.36%、84.76%,振幅较大的相关个股有Immunoprecise Antibodies Ltd.、Lexeo Therapeutics, Inc.、Mersana Therapeutics, Inc.,振幅分别为14.89%、10.88%、10.27%。Zentalis Pharmaceuticals, Inc.公司简介:Zentalis Pharmaceuticals Inc是一家临床阶段的生物制药公司,专注于发现和开发针对癌症基本生物学途径的小分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111322323395be2380&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111322323395be2380&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZNTL","BK4139"],"gpt_icon":0},{"id":"2481100131","title":"Zentalis Pharmaceuticals, Inc.盘中异动 大幅上涨5.25%报4.01美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481100131","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481100131?lang=zh_cn&edition=full","pubTime":"2024-11-08 23:10","pubTimestamp":1731078636,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日23时10分,Zentalis Pharmaceuticals, Inc.股票出现异动,股价大幅拉升5.25%。Zentalis Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.50%。Zentalis Pharmaceuticals, Inc.公司简介:Zentalis Pharmaceuticals Inc是一家临床阶段的生物制药公司,专注于发现和开发针对癌症基本生物学途径的小分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108231037abae538b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108231037abae538b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ZNTL"],"gpt_icon":0},{"id":"2481180390","title":"Zentalis Pharmaceuticals, Inc.盘中异动 股价大涨5.08%报4.04美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481180390","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481180390?lang=zh_cn&edition=full","pubTime":"2024-11-07 23:50","pubTimestamp":1730994653,"startTime":"0","endTime":"0","summary":"北京时间2024年11月07日23时50分,Zentalis Pharmaceuticals, Inc.股票出现异动,股价快速拉升5.08%。Zentalis Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.28%。其相关个股中,Ensysce Biosciences, Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Celularity Inc.涨幅较大,Ensysce Biosciences, Inc.、Elevai Labs, Inc.、Cyclacel Pharmaceuticals, Inc.较为活跃,换手率分别为769.54%、172.79%、95.44%,振幅较大的相关个股有Celularity Inc.、180 Life Sciences Corp C/Wts 07/11/2025、Ensysce Biosciences, Inc.,振幅分别为84.83%、68.89%、57.79%。Zentalis Pharmaceuticals, Inc.公司简介:Zentalis Pharmaceuticals Inc是一家临床阶段的生物制药公司,专注于发现和开发针对癌症基本生物学途径的小分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107235053a22115b8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107235053a22115b8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ZNTL"],"gpt_icon":0},{"id":"2481988810","title":"Zentalis Pharmaceuticals, Inc.盘中异动 早盘大幅拉升5.29%报3.98美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481988810","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481988810?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:31","pubTimestamp":1730903505,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日22时31分,Zentalis Pharmaceuticals, Inc.股票出现异动,股价急速上涨5.29%。Zentalis Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.91%。其相关个股中,Sonnet Biotherapeutics Holdings, Inc.、Sab Biotherapeutics Inc C/Wts 22/10/2026 、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大,Sonnet Biotherapeutics Holdings, Inc.、Elevai Labs, Inc.、Zyversa Therapeutics, Inc.较为活跃,换手率分别为1028.05%、98.18%、48.89%,振幅较大的相关个股有Vaxcyte, Inc.、Fate Therapeutics, Inc.、Nurix Therapeutics, Inc.,振幅分别为107.85%、107.84%、106.06%。Zentalis Pharmaceuticals, Inc.公司简介:Zentalis Pharmaceuticals Inc是一家临床阶段的生物制药公司,专注于发现和开发针对癌症基本生物学途径的小分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106223145a21d2a34&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106223145a21d2a34&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ZNTL"],"gpt_icon":0},{"id":"2481360756","title":"Zentalis Pharmaceuticals Inc 预计每股亏损 91 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2481360756","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481360756?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:09","pubTimestamp":1730902141,"startTime":"0","endTime":"0","summary":" * Zentalis Pharmaceuticals Inc 将于11月8日公布截至2024年9月30日的财报() 预计该公司的季度收入将保持不变。* * LSEG分析师对Zentalis Pharmaceuticals Inc的平均预期是每股亏损91美分。* 华尔街对 Zentalis Pharmaceuticals Inc 的 12 个月目标价中位数为 8.00 美元,高于其上次收盘价 3.78 美元。11月6日 - 上一季度业绩。除非另有说明,否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问,请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Zentalis Pharmaceuticals Inc 预计每股亏损 91 美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZNTL"],"gpt_icon":0},{"id":"2481688066","title":"Zentalis Pharmaceuticals, Inc.盘中异动 股价大跌5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481688066","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481688066?lang=zh_cn&edition=full","pubTime":"2024-11-05 22:34","pubTimestamp":1730817284,"startTime":"0","endTime":"0","summary":"北京时间2024年11月05日22时34分,Zentalis Pharmaceuticals, Inc.股票出现异动,股价大幅跳水5.09%。Zentalis Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.01%。Zentalis Pharmaceuticals, Inc.公司简介:Zentalis Pharmaceuticals Inc是一家临床阶段的生物制药公司,专注于发现和开发针对癌症基本生物学途径的小分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105223444aba23d08&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105223444aba23d08&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ZNTL"],"gpt_icon":0},{"id":"2480581759","title":"Zentalis Pharmaceuticals, Inc.盘中异动 股价大涨5.12%报3.49美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480581759","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480581759?lang=zh_cn&edition=full","pubTime":"2024-11-04 22:34","pubTimestamp":1730730867,"startTime":"0","endTime":"0","summary":"北京时间2024年11月04日22时34分,Zentalis Pharmaceuticals, Inc.股票出现异动,股价大幅上涨5.12%。Zentalis Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.20%。其相关个股中,Briacell Therapeutics Corp C/Wts 24/02/2025、Disc Medicine, Inc.、Nls Pharmaceutics Ltd.涨幅较大,Nls Pharmaceutics Ltd.、Elevai Labs, Inc.、Gri Bio, Inc.较为活跃,换手率分别为236.20%、138.54%、44.54%,振幅较大的相关个股有Briacell Therapeutics Corp C/Wts 24/02/2025、Psyence Biomedical Ltd C/Wts 25/01/2029、Sab Biotherapeutics Inc C/Wts 22/10/2026 ,振幅分别为29.83%、22.67%、13.75%。Zentalis Pharmaceuticals, Inc.公司简介:Zentalis Pharmaceuticals Inc是一家临床阶段的生物制药公司,专注于发现和开发针对癌症基本生物学途径的小分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104223427ab9ebf86&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104223427ab9ebf86&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZNTL","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.zentalis.com","stockEarnings":[{"period":"1week","weight":-0.0639},{"period":"1month","weight":-0.0201},{"period":"3month","weight":-0.3057},{"period":"6month","weight":-0.3832},{"period":"1year","weight":-0.7839},{"period":"ytd","weight":-0.8066}],"compareEarnings":[{"period":"1week","weight":-0.0302},{"period":"1month","weight":-0.0071},{"period":"3month","weight":0.0314},{"period":"6month","weight":0.0764},{"period":"1year","weight":0.2517},{"period":"ytd","weight":0.2331}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Zentalis Pharmaceuticals, Inc.于2014年12月23日在特拉华州以Zeno Pharmaceuticals,Inc.的身份注册成立。Zentalis Pharmaceuticals,Inc.是一家临床阶段制药公司,致力于发现和开发针对癌症基本生物途径的临床分化的新型小分子疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.157062},{"month":2,"riseRate":0.5,"avgChangeRate":0.007508},{"month":3,"riseRate":0.5,"avgChangeRate":-0.019358},{"month":4,"riseRate":0.5,"avgChangeRate":-0.018876},{"month":5,"riseRate":0.6,"avgChangeRate":0.118909},{"month":6,"riseRate":0.4,"avgChangeRate":-0.106955},{"month":7,"riseRate":0.4,"avgChangeRate":-0.068858},{"month":8,"riseRate":0.2,"avgChangeRate":0.016639},{"month":9,"riseRate":0.2,"avgChangeRate":-0.089748},{"month":10,"riseRate":0.6,"avgChangeRate":0.026783},{"month":11,"riseRate":0.6,"avgChangeRate":0.039766},{"month":12,"riseRate":0.6,"avgChangeRate":0.022503}],"exchange":"NASDAQ","name":"Zentalis Pharmaceuticals, LLC","nameEN":"Zentalis Pharmaceuticals, LLC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Zentalis Pharmaceuticals, LLC(ZNTL)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Zentalis Pharmaceuticals, LLC(ZNTL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Zentalis Pharmaceuticals, LLC,ZNTL,Zentalis Pharmaceuticals, LLC股票,Zentalis Pharmaceuticals, LLC股票老虎,Zentalis Pharmaceuticals, LLC股票老虎国际,Zentalis Pharmaceuticals, LLC行情,Zentalis Pharmaceuticals, LLC股票行情,Zentalis Pharmaceuticals, LLC股价,Zentalis Pharmaceuticals, LLC股市,Zentalis Pharmaceuticals, LLC股票价格,Zentalis Pharmaceuticals, LLC股票交易,Zentalis Pharmaceuticals, LLC股票购买,Zentalis Pharmaceuticals, LLC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Zentalis Pharmaceuticals, LLC(ZNTL)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Zentalis Pharmaceuticals, LLC(ZNTL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}